Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe pediatric Crohn's Disease response to sargramostim in
patients with or without steroid therapy at two possible dosage levels.